Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q3 EPS of ($0.92), $0.02 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.